Percutaneous Deep Foot Vein Arterialization IVUS-Guided in No-Option Critical Limb Ischemia Diabetic Patients

被引:17
|
作者
Cangiano, Gianluca [1 ]
Corvino, Fabio [1 ]
Giurazza, Francesco [1 ]
De Feo, Eugenio Maria [2 ]
Fico, Francesca [2 ]
Palumbo, Vincenzo [2 ]
Amodio, Francesco [1 ]
Silvestre, Mattia [1 ]
Corvino, Antonio [3 ]
Niola, Raffaella [1 ]
机构
[1] AORN A Cardarelli, Intervent Radiol Dept, Naples, Italy
[2] AORN A Cardarelli, Diabet Foot Unit, Dept Gen & Specialist Med, Naples, Italy
[3] Univ Naples Parthenope, Motor Sci & Wellness Dept, Via F Acton 38, I-80133 Naples, Italy
关键词
critical limb ischemia; diabetic foot; arterio-venous fistula; deep vein arterialization; ulcer; VENOUS ARTERIALIZATION; SALVAGE;
D O I
10.1177/1538574420965743
中图分类号
R61 [外科手术学];
学科分类号
摘要
Purpose: To report our clinical experience with IVUS-guided percutaneous deep vein arterialization (pDVA) to treat chronic critical limb ischemia (cCLI) patients with no-endovascular or surgical options approach due to creation of an arteriovenous fistula (AVF). Materials and Methods: In a 2 years period, 14 no-option cCLI patients were treated with percutaneous deep vein arterialization (pDVA) by creating an AVF with a IVUS-guided system between posterior tibial artery and its satellite deep vein. Technical success was defined as successful AVF creation and venous perfusion of the wound site. Patients' characteristics, procedure details, mortality and wound outcomes were assessed prospectively. Results: Successful pDVA was successfully performed in all patients (mean age 82 years) without any procedural complications. Clinical improvement was achieved in all patients with resolution of rest pain, tissue formation of granulation tissue or both; only 3 major amputations were performed within the study period with a limb salvage rate of 78%. Median wound healing time was 4.8 months. Conclusion: pDVA is a safe and feasible revascularization technique alternative in no-option cCLI patients.
引用
收藏
页码:58 / 63
页数:6
相关论文
共 50 条
  • [31] Intravascular lithotripsy-assisted percutaneous deep vein arterialization for no-option chronic limb-threatening patients and heavily calcified tibial occlusive disease
    Kapetanios, Dimitrios
    Czihal, Michael
    Tsilimparis, Nikolaos
    Torsello, Giovanni
    Rieck, Julian
    Stavroulakis, Konstantinos
    VASCULAR, 2024,
  • [32] PROMISE I: Early feasibility study of the LimFlow System for percutaneous deep vein arterialization in no-option chronic limb-threatening ischemia: 12-month results
    Clair, Daniel G.
    Mustapha, Jihad A.
    Shishehbor, Mehdi H.
    Schneider, Peter A.
    Henao, Steve
    Bernardo, Nelson N.
    Deaton, David H.
    JOURNAL OF VASCULAR SURGERY, 2021, 74 (05) : 1626 - 1635
  • [33] Percutaneous Deep Venous Arterialization for Severe Critical Limb Ischemia in Patients With No Option of Revascularization: Early Experience From Two European Centers
    C. Del Giudice
    D. Van Den Heuvel
    J. Wille
    T. Mirault
    E. Messas
    R. Ferraresi
    S. Kum
    M. Sapoval
    CardioVascular and Interventional Radiology, 2018, 41 : 1474 - 1480
  • [34] Percutaneous Deep Venous Arterialization for Severe Critical Limb Ischemia in Patients With No Option of Revascularization: Early Experience From Two European Centers
    Del Giudice, C.
    Van Den Heuvel, D.
    Wille, J.
    Mirault, T.
    Messas, E.
    Ferraresi, R.
    Kum, S.
    Sapoval, M.
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2018, 41 (10) : 1474 - 1480
  • [35] A review of percutaneous deep vein arterialization for the treatment of nonreconstructable chronic limb threatening ischemia
    Clair, Daniel
    Gibbons, Michael
    SEMINARS IN VASCULAR SURGERY, 2021, 34 (04) : 188 - 194
  • [36] Correction to: Percutaneous Deep Venous Arterialization for Severe Critical Limb Ischemia in Patients With No Option of Revascularization: Early Experience From Two European Centers
    C. Del Giudice
    D. Van Den Heuvel
    J. Wille
    T. Mirault
    E. Messas
    R. Ferraresi
    S. Kum
    M. Sapoval
    CardioVascular and Interventional Radiology, 2018, 41 : 1810 - 1810
  • [37] Interim Results of the PROMISE I Trial to Investigate the LimFlow System of Percutaneous Deep Vein Arterialization for the Treatment of Critical Limb Ischemia
    Mustapha, J. A.
    Saab, Fadi A.
    Clair, Daniel
    Schneider, Peter
    JOURNAL OF INVASIVE CARDIOLOGY, 2019, 31 (03): : 57 - 63
  • [38] Percutaneous deep vein aRterialization for the treatment Of late stage critical liMb ISchEmia, The PROMISE Trial: Early Feasibility Interim Results
    Mustapha, Jihad
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (13) : B148 - B148
  • [39] FEASIBILITY OF AUTOLOGOUS MESENCHYMAL STEM CELLS THERAPY FOR PATIENTS WITH NO-OPTION CRITICAL LIMB ISCHEMIA
    Mohamed, S.
    Howard, L.
    Duffy, A.
    Finnerty, A.
    Holohan, M.
    Doroshenkova, T.
    McInerney, V.
    Hayat, A.
    Krawczyk, J.
    Naughton, S.
    Tarpey, M.
    Moloney, T.
    Kavanagh, E.
    Liews, A.
    Tubassam, M.
    Walsh, S.
    O'Brien, T.
    CYTOTHERAPY, 2017, 19 (05) : S108 - S109
  • [40] Percutaneous deep vein arterialization using off-the-shelf devices for chronic limb threatening ischemia
    Gupta, Aakanksha
    Fadoul, Mikael
    Mcmackin, Katherine
    Balderman, Joshua
    V. Lombardi, Joseph
    Tjaden, Bruce L., Jr.
    JOURNAL OF VASCULAR SURGERY CASES INNOVATIONS AND TECHNIQUES, 2023, 9 (03):